Bacterial translocation (BT) in cirrhosis
Regular follow-up with a healthcare provider is recommended to monitor treatment response and tolerability
STEP-4 gave every participant a 20-week course of semaglutide 2.4 mg once weekly, and produced a mean weight loss of 10.6%, before randomisation to either continued semaglutide treatment or exchange to placebo for an additional 48 weeks
Potential Future Users: Reasons for considering usage, weight loss/health goals, likelihood of use, and what factors will be most influential in determining usage
However, its always best to consult a healthcare professional to ensure its appropriate for your needs and to avoid unnecessary supplementation
As the demand for weight loss and diabetes management solutions continues to rise, many consumers may be tempted to explore over-the-counter (OTC) alternatives to Ozempic